Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Clinical trial NCT01864109 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01864109
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.